Breo Ellipta
Active Ingredient(s): Fluticasone Furoate + Vilanterol TrifenatateFDA Approved: * May 10, 2013
Pharm Company: * GLAXO GRP LTD
Category: Lungs (Pulmonary)
Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1][2]. The combination is also approved for the treatment of asthma in Europe, Japan[3] and New Zealand.[4] Vilanterol is available in following combinations: ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.2 Discussions
Dosage List
Popular Topics
I was given a sample of breo ellipta for bronchitis.. just bronchitis. I was on it for 2 days when I ended up in the hos...
Has anyone had an itchy facial rash that got puffy and turned really red, and felt pretty hot? Anoro Ellipta is the only...
Does anybody know what meds should not be taken with Trelegy Ellipta? I take Toprol-XL, Norvasc, Protonix, Xarelto, Proa...
I am taking Incruse Ellipta 62.5mcg inhaler (1 puff by mouth per day). It makes me have red blood spots on both arms. I ...
should breo be used by a patient who has had an ablation for atrial flutter ## Hello, Susannah! How are you? This does c...